Navigation Links
Regulus to Present at Future Leaders in the Biotech Industry Conference
Date:3/28/2013

tp://www.regulusrx.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements associated with Regulus' expectations regarding future therapeutic and commercial potential of Regulus' business plans, technologies and intellectual property related to microRNA therapeutics being discovered and developed by Regulus.  Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "intends," "will," "goal," "potential" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Regulus' current expectations and involve assumptions that may never materialize or may prove to be incorrect.  Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks associated with the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  These and other risks concerning Regulus' programs are described in additional detail in Regulus' SEC filings.  All forward-looking statements contained in this press release speak only as of the date on which they were made. Regulus undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.


'/>"/>
SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Regulus to Present at Cowen and Company 33rd Annual Healthcare Conference
2. Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
3. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
4. Regulus to Present at Two Upcoming Investor Conferences
5. Regulus Appoints Mark G. Foletta to its Board of Directors
6. Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
7. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
8. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
9. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
10. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012
11. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... The number of people overdosing from opioid ... Twenty-three percent of the workforce has misused prescription painkillers, ... Health, making opioid use a serious threat to employee ... the correct dosage with a valid prescription, subtle impairment ... National Safety Council released a guide for employers, ...
(Date:7/22/2014)... TOTOWA, N.J. , July 22, 2014 ... Florida,s first 3-way Kidney Paired Donation ... landmark surgical procedures happened on July 9 at the ... Miami, Fla. ... pairs who are not compatible for kidney transplant with ...
(Date:7/22/2014)... Elekta (NSE:EKTAb) and Royal Philips ... Foundation Trust ( Manchester, UK ), a ... is to develop the clinical value of an integrated ... a system would, in principle, improve the practice of ... "The Christie was an essential participant in the ...
Breaking Medicine Technology:5 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4
... for maintaining a healthy immune systemPURCHASE, N.Y., Jan. 6 ... Cancer (60(5), 643-651) by researchers at Kansai Medical ... Hexose Correlated Compound) enhances immune function by increasing the ... part of the immune system responsible for presenting foreign ...
... 6 Pacira Pharmaceuticals, Inc., an,acute care specialty ... in two pivotal Phase III SIMPLE trials to ... administration of EXPAREL(TM),(DepoBupivacaine) for prolonged postoperative analgesia. , ... in hemorrhoidectomy and in total knee,arthroplasty (TKA) are ...
Cached Medicine Technology:Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3
(Date:7/22/2014)... July 22, 2014 The Restful Jaw ... the Restful Jaw ®. The FDA-registered external device ... while minimizing jaw pain, fatigue and soreness during dental ... treatment times when patients do not need to take ... The Restful Jaw is a vital solution in helping ...
(Date:7/22/2014)... University of the Pacific's Arthur A. ... of its state-of-the-art, $151 million campus this month. The ... San Francisco's South of Market (SoMa) district and houses ... patients will now be greeted by a wall of ... , Advanced Kiosks engineering team designed custom software to ...
(Date:7/22/2014)... HealthDay Reporter , MONDAY, July 21, 2014 (HealthDay ... high school may take fewer health risks than their peers ... of low-income Los Angeles teens, found that those who attended ... binge-drink, have multiple sex partners or take certain other health ... kids" being more likely to go to good schools, researchers ...
(Date:7/22/2014)... 21, 2014) Investigators at the Cedars-Sinai Samuel ... multistep investigational treatment for one of the most ... advanced pancreatic cancer. , Locally advanced pancreatic ... solid tumor, with a cumulative five-year survival rate ... disease. Surgery is rarely an option for patients ...
(Date:7/22/2014)... like electroconvulsive therapy (ECT) and transcranial magnetic stimulation ... depression. Like antidepressant medications, however, they typically have ... receive several weeks of regular ECT treatments before ... is an impetus to develop antidepressant treatments that ... stimulation (LFMS) is one such potential new treatment ...
Breaking Medicine News(10 mins):Health News:Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw 2Health News:Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw 3Health News:iKiosks Are Gateway to Premier Dental Facility 2Health News:iKiosks Are Gateway to Premier Dental Facility 3Health News:Good Schools May Be Good for a Teen's Health, Too 2Health News:Good Schools May Be Good for a Teen's Health, Too 3Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 2Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 3Health News:Low strength brain stimulation may be effective for depression 2
... who take a multivitamin pill may think they can smoke ... of cigarettes, according to a new study. Researchers found ... reduce their risk of cancer, allowing them to light up ... virtuous behavior for a subsequent indulgence, known as the "licensing ...
... 4 (HealthDay News) -- People living in a region of ... known to have significantly higher rates of stroke deaths than ... are also at greater risk for sepsis, a severe illness ... examined death rates from sepsis across the United States," said ...
... Duke University Medical Center and Johns Hopkins University could ... therapy to treat the second most common type of ... for the primary cancer genes involved in the development ... the probable mutations, but not the particular gene information. ...
... , THURSDAY, Aug. 4 (HealthDay News) -- A ... common form of brain cancer appears to reveal the biological ... map by sequencing protein-coding genes in seven samples of tissue ... genes (CIC and FUBP1) not previously associated with those types ...
... Spanish . , Kidney transplant from a living donor, ... those affected by particular conditions, results in increased organ survival ... the mid-90 despite the high rate of cadaveric donation. According ... living donor kidney transplants were made, which represents 11% of ...
... U.S. meat processor Cargill announced late Wednesday that it was ... about 36 million pounds of ground turkey linked to an ... closer to the source of the outbreak, which the U.S. ... Californian and sickened at least 76 others across 26 states ...
Cached Medicine News:Health News:Smokers Mistakenly Believe Vitamins Protect Them From Cancer 2Health News:U.S. 'Stroke Belt' May Also Be 'Sepsis Belt' 2Health News:Elusive gene mutations found for malignant brain tumor 2Health News:Scientists May Have Found Missing Link to Common Brain Cancer 2Health News:Minimal scar techniques in living donors for kidney transplant 2Health News:Minimal scar techniques in living donors for kidney transplant 3Health News:Minimal scar techniques in living donors for kidney transplant 4Health News:Minimal scar techniques in living donors for kidney transplant 5Health News:Cargill Begins Massive Recall of Turkey Linked to Salmonella Outbreak 2Health News:Cargill Begins Massive Recall of Turkey Linked to Salmonella Outbreak 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: